Detalhe da pesquisa
1.
Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery.
World J Urol
; 34(5): 687-93, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26407582
2.
Use of Adjuvant Chemotherapy in Patients with Advanced Bladder Cancer after Neoadjuvant Chemotherapy.
Bladder Cancer
; 3(3): 181-189, 2017 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28824946
3.
Reply to Valeria Panebianco, Francesco Del Giudice, Yoshifumi Narumi, Giuseppe Simone, Ettore De Berardinis, and James Catto's Letter to the Editor re: Helena Vila-Reyes, G. Joel De Castro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36.
Eur Urol
; 79(2): e54-e55, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33248798
4.
Robot-assisted radical cystoprostatectomy in the post-radiation and chemotherapy patient.
J Robot Surg
; 2(4): 269, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27637800